Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
351
datasets available to search
ShareScore release 0.9.0
Dataset results
351 results for “empagliflozin”
Drug Drug Interaction of Empagliflozin (BI 10773) and Warfarin in Healthy Volunteers
ClinicalTrials.gov study NCT01111331. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Based on Data From German Registries That Looks at Characteristics of People Who Take the Medicine Empagliflozin for Type 2 Diabetes
ClinicalTrials.gov study NCT04098575. IPD Sharing: NO. Countries: 1. Publications: 0.
This Study Combines Data From 3 Other Studies Testing Empagliflozin in Patients With Diabetes or With Chronic Heart Failure. The Study Looks at the Numbers of Patients Who Had Lower Limb Amputations
ClinicalTrials.gov study NCT04937816. IPD Sharing: NO. Countries: 1. Publications: 0.
This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills
ClinicalTrials.gov study NCT03629054. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes
ClinicalTrials.gov study NCT06021145. IPD Sharing: YES. Countries: 1. Publications: 0.
Empagliflozin Versus Linagliptin in Renal Ransplant Recipients With Diabetes Mellitus
ClinicalTrials.gov study NCT06098625. IPD Sharing: NO. Countries: 0. Publications: 7.
A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin
ClinicalTrials.gov study NCT04233801. IPD Sharing: YES. Countries: 1. Publications: 0.
Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability
ClinicalTrials.gov study NCT01211197. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RNA-expression analysis on smooth muscle cells of diabetic donors after empagliflozin treatment
GEO Series GSE189538. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Empagliflozin Ameliorates Aldehyde Dehydrogenase 2 Deficiency-induced Endothelial Dysfunction
GEO Series GSE184419. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.
Empagliflozin in acute myocardial infarction reduces no-reflow and preserves cardiac function by preventing endothelial damage
GEO Series GSE255933. Mus musculus. 38 samples. Type: Expression profiling by high throughput sequencing.
Empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of vascular smooth muscle cells
GEO Series GSE243752. Rattus norvegicus. 6 samples. Type: Expression profiling by high throughput sequencing.
Figure 2 from: Obaid KA, Fawzi HA (2024) Evaluation of empagliflozin efficacy as a promising anti-aging treatment in mice: In-vivo study. Pharmacia 71: 1-9. https://doi.org/10.3897/pharmacia.71.e116184
Figure 2 Assessment of inflammatory and oxidative stress markers.
Figure 3 from: Obaid KA, Fawzi HA (2024) Evaluation of empagliflozin efficacy as a promising anti-aging treatment in mice: In-vivo study. Pharmacia 71: 1-9. https://doi.org/10.3897/pharmacia.71.e116184
Figure 3 Assessment of COL-1 and -3 levels.
Figure 1 from: Obaid KA, Fawzi HA (2024) Evaluation of empagliflozin efficacy as a promising anti-aging treatment in mice: In-vivo study. Pharmacia 71: 1-9. https://doi.org/10.3897/pharmacia.71.e116184
Figure 1 Flow chart of the study.
Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department
ClinicalTrials.gov study NCT06683053. IPD Sharing: NO. Countries: 1. Publications: 0.
Effects of Empagliflozin in Reducing Oxidative Stress After Kidney Transplantation
ClinicalTrials.gov study NCT04918407. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema
ClinicalTrials.gov study NCT02985242. IPD Sharing: NO. Countries: 1. Publications: 0.
Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure
ClinicalTrials.gov study NCT07038356. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Empagliflozin in Pulmonary Arterial Hypertension
ClinicalTrials.gov study NCT05493371. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.